310 related articles for article (PubMed ID: 28573448)
1. Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers.
Lin C; Clark R; Tu P; Bosworth HB; Zullig LL
Breast Cancer Res Treat; 2017 Sep; 165(2):247-260. PubMed ID: 28573448
[TBL] [Abstract][Full Text] [Related]
2. The Association Between Patient-Reported and Objective Oral Anticancer Medication Adherence Measures: A Systematic Review
.
Atkinson TM; Rodríguez VM; Gordon M; Avildsen IK; Emanu JC; Jewell ST; Anselmi KA; Ginex PK
Oncol Nurs Forum; 2016 Sep; 43(5):576-82. PubMed ID: 27541550
[TBL] [Abstract][Full Text] [Related]
3. Predictors of adherence to oral anticancer medications: An analysis of 2010-2018 US nationwide claims.
Vyas A; Descoteaux A; Kogut S; Parikh MA; Campbell PJ; Green A; Westrich K
J Manag Care Spec Pharm; 2022 Aug; 28(8):831-844. PubMed ID: 35876294
[No Abstract] [Full Text] [Related]
4. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
[TBL] [Abstract][Full Text] [Related]
5. Identifying adherence barriers to oral endocrine therapy among breast cancer survivors.
Paranjpe R; John G; Trivedi M; Abughosh S
Breast Cancer Res Treat; 2019 Apr; 174(2):297-305. PubMed ID: 30523459
[TBL] [Abstract][Full Text] [Related]
6. Barriers and Facilitators of Adherence to Oral Anticancer Medications Among Women with Breast Cancer: A Qualitative Study.
Onwusah DO; Ojewole EB; Manyangadze T; Chimbari MJ
Patient Prefer Adherence; 2023; 17():2821-2839. PubMed ID: 37953981
[TBL] [Abstract][Full Text] [Related]
7. Adherence to Oral Anticancer Medications Among Women With Breast Cancer in Africa: A Scoping Review.
Onwusah DO; Ojewole EB; Chimbari MJ
JCO Glob Oncol; 2023 Jan; 9():e2100289. PubMed ID: 36689700
[TBL] [Abstract][Full Text] [Related]
8. Adherence to targeted oral anticancer medications.
Geynisman DM; Wickersham KE
Discov Med; 2013 Apr; 15(83):231-41. PubMed ID: 23636140
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Provider Adherence to Recommended Monitoring Parameters for Oral Anticancer Medications.
Redelico TJ; Walton SM; LaFollette J; Adams Curry M; Bernal-Mizrachi L
J Oncol Pract; 2018 Jul; 14(7):e446-e450. PubMed ID: 29813011
[TBL] [Abstract][Full Text] [Related]
10. Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients.
Jacob Arriola KR; Mason TA; Bannon KA; Holmes C; Powell CL; Horne K; O'Regan R
Patient Educ Couns; 2014 Apr; 95(1):98-103. PubMed ID: 24492157
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing oral adherence: qualitative metasummary and triangulation with quantitative evidence.
Johnson LA
Clin J Oncol Nurs; 2015 Jun; 19(3 Suppl):6-30. PubMed ID: 26030389
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial determinants of adherence with oral anticancer treatment: 'we don't need no education'.
Kaptein AA; Schoones JW; van der Meer PB; Matsuda A; Murray M; Heimans L; Kroep JR
Acta Oncol; 2021 Jan; 60(1):87-95. PubMed ID: 33151764
[TBL] [Abstract][Full Text] [Related]
13. Patients' Perception of App-based Educational and Behavioural Interventions for Enhancing Oral Anticancer Medication Adherence.
Ali EE; Leow JL; Chew L; Yap KY
J Cancer Educ; 2018 Dec; 33(6):1306-1313. PubMed ID: 28707206
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research.
Van Liew JR; Christensen AJ; de Moor JS
J Cancer Surviv; 2014 Sep; 8(3):521-31. PubMed ID: 24986227
[TBL] [Abstract][Full Text] [Related]
15. Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review.
Hurtado-de-Mendoza A; Cabling ML; Lobo T; Dash C; Sheppard VB
Clin Breast Cancer; 2016 Aug; 16(4):247-255.e3. PubMed ID: 27133733
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.
Lambert LK; Balneaves LG; Howard AF; Gotay CC
Breast Cancer Res Treat; 2018 Feb; 167(3):615-633. PubMed ID: 29110151
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluations of oral medications for breast cancer treatment in the U.S.: a systematic review with a focus on cost-effectiveness threshold.
Park SK; Chun HK; Park C
Expert Rev Pharmacoecon Outcomes Res; 2019 Dec; 19(6):633-643. PubMed ID: 31608715
[No Abstract] [Full Text] [Related]
18. Cost-effectiveness analyses of targeted oral anti-cancer drugs: a systematic review.
Smieliauskas F; Chien CR; Shen C; Geynisman DM; Shih YC
Pharmacoeconomics; 2014 Jul; 32(7):651-80. PubMed ID: 24821281
[TBL] [Abstract][Full Text] [Related]
19. Patient factors associated with diabetes medication adherence at different health literacy levels: a cross-sectional study at a family medicine clinic.
Huang YM; Shiyanbola OO; Chan HY; Smith PD
Postgrad Med; 2020 May; 132(4):328-336. PubMed ID: 32233892
[TBL] [Abstract][Full Text] [Related]
20. Patients' perspective of barriers and facilitators to taking long-term controller medication for asthma: a novel taxonomy.
Peláez S; Lamontagne AJ; Collin J; Gauthier A; Grad RM; Blais L; Lavoie KL; Bacon SL; Ernst P; Guay H; McKinney ML; Ducharme FM
BMC Pulm Med; 2015 Apr; 15():42. PubMed ID: 25907709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]